Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment
Open Access
- 12 March 1999
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (11) , 1884-1893
- https://doi.org/10.1038/sj.bjc.6690300
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human EvolutionCell Host & Microbe, 2008
- Genome analysis of the platypus reveals unique signatures of evolutionNature, 2008
- Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3GFEBS Letters, 2007
- Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequencesNature, 2007
- The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domainsVirology, 2007
- Cellular inhibitors of long interspersed element 1 and Alu retrotranspositionProceedings of the National Academy of Sciences, 2006
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA MutatorsMolecular Cell, 2002
- T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. ThorntonJournal of Molecular Biology, 2000
- Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast CancerNew England Journal of Medicine, 1992